MX2009003925A - Metodos y composiciones para el tratamiento de enfermedades vaginales, empleando enzimas que producen peroxido y peroxidasas. - Google Patents

Metodos y composiciones para el tratamiento de enfermedades vaginales, empleando enzimas que producen peroxido y peroxidasas.

Info

Publication number
MX2009003925A
MX2009003925A MX2009003925A MX2009003925A MX2009003925A MX 2009003925 A MX2009003925 A MX 2009003925A MX 2009003925 A MX2009003925 A MX 2009003925A MX 2009003925 A MX2009003925 A MX 2009003925A MX 2009003925 A MX2009003925 A MX 2009003925A
Authority
MX
Mexico
Prior art keywords
treatment
peroxidases
compositions
methods
vaginal diseases
Prior art date
Application number
MX2009003925A
Other languages
English (en)
Inventor
Michael Pellico
Rajvinder Kaur Atwal
Original Assignee
Laclede Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laclede Inc filed Critical Laclede Inc
Publication of MX2009003925A publication Critical patent/MX2009003925A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/02—Oxidoreductases acting on a peroxide as acceptor (1.11) with H2O2 as acceptor, one oxygen atom of which is incorporated into the product (1.11.2)
    • C12Y111/02002—Myeloperoxidase (1.11.2.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición terapéutica para administración vaginal con base en la generación de un anión biocida por medio de una reacción enzimática catalizada por una peroxidasa; la peroxidasa utilizada por la enzima de proxidasa puede ser endógeno o puede generarse por la acción de una enzima de oxidasa en un substrato adecuado; las composiciones terapéuticas de acuerdo con esta invención son útiles para el tratamiento de enfermedades y afecciones vaginales que incluyen infecciones bacterianas y fúngicas.
MX2009003925A 2006-10-10 2007-09-28 Metodos y composiciones para el tratamiento de enfermedades vaginales, empleando enzimas que producen peroxido y peroxidasas. MX2009003925A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82893306P 2006-10-10 2006-10-10
PCT/US2007/079840 WO2008045696A2 (en) 2006-10-10 2007-09-28 Methods and compositions for the treatment of vaginal diseases employing peroxide-producing enzymes and peroxidases

Publications (1)

Publication Number Publication Date
MX2009003925A true MX2009003925A (es) 2009-10-26

Family

ID=39283509

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003925A MX2009003925A (es) 2006-10-10 2007-09-28 Metodos y composiciones para el tratamiento de enfermedades vaginales, empleando enzimas que producen peroxido y peroxidasas.

Country Status (9)

Country Link
US (2) US20100111920A1 (es)
EP (1) EP2073836A4 (es)
JP (2) JP5337701B2 (es)
KR (1) KR20090094245A (es)
AU (1) AU2007307921B2 (es)
BR (1) BRPI0719220A2 (es)
CA (1) CA2673497A1 (es)
MX (1) MX2009003925A (es)
WO (1) WO2008045696A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5337701B2 (ja) * 2006-10-10 2013-11-06 ラクリード、インコーポレイテッド ペルオキシド生成酵素及びペルオキシダーゼを使用した膣疾患の治療のための方法及び組成物
GB2451452A (en) * 2007-07-30 2009-02-04 Donald Henry Yates A lubricant formulation
EP2510944A1 (en) * 2011-04-15 2012-10-17 National University of Ireland, Galway Treatment of bacterial infections
FR2980974B1 (fr) 2011-10-10 2014-02-21 Alaxia Composition comprenant un sel d'hypothiocyanite d'un cation alcalin, a l'etat solide
CA2975197A1 (en) * 2015-02-03 2016-08-11 Matoke Holdings Limited Antimicrobial fibers and compositions
EP3085417A1 (de) * 2015-04-24 2016-10-26 COR S.a.r.l. Gleitmittel
US9833720B2 (en) 2015-06-22 2017-12-05 Kma Concepts Limited Clip launcher system with interconnecting projectile
ES2685002B1 (es) * 2017-03-31 2019-07-17 Itf Res Pharma Slu Formulaciones lubricantes
CN107130004A (zh) * 2017-07-03 2017-09-05 东北农业大学 玉米缪与大豆水酶法水解液混合发酵酒精的方法
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
JP7281729B2 (ja) * 2019-01-30 2023-05-26 学校法人帝京大学 抗真菌用組成物
CN112458027B (zh) * 2020-12-16 2022-08-02 江南大学 一株格氏乳杆菌及其缓解和治疗高尿酸血症的用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178362A (en) * 1969-06-03 1979-12-11 Telec S.A. Enzymatic dentifrices
US4340448A (en) * 1978-08-28 1982-07-20 University Of Pittsburgh Potentiometric detection of hydrogen peroxide and apparatus therefor
US4269822A (en) * 1979-07-20 1981-05-26 Laclede Professional Products, Inc. Antiseptic dentifrice
US4578265A (en) * 1981-08-13 1986-03-25 Laclede Professional Products, Inc. Di-enzymatic dentifrice
US4370199A (en) * 1981-11-09 1983-01-25 Westvaco Corporation Enzymatic catalyzed biocide system
US4564519A (en) * 1983-06-06 1986-01-14 Laclede Professional Products, Inc. Di-enzymatic chewable dentifrice
US4576817A (en) * 1984-06-07 1986-03-18 Laclede Professional Products, Inc. Enzymatic bandages and pads
US4578365A (en) * 1984-11-26 1986-03-25 General Electric Company High thermal conductivity ceramic body of aluminum nitride
FR2574160A1 (fr) * 1984-11-30 1986-06-06 Electricite De France Grille de foyer realisee a partir d'elements permettant un controle ameliore de l'apport en air primaire
DK501686A (da) * 1986-10-20 1988-04-21 Otto Melchior Poulsen Enzymholdigt, baktericidt middel samt tandplejemidler og saarbehandlingsmidler, som indeholder det
SE8702831L (sv) * 1987-07-10 1989-01-11 Ewos Ab Microbicid komposition
JPH0248534A (ja) * 1988-07-28 1990-02-19 Bio Serae Sa:Soc 抗菌組成物の配合方法及び配合された抗菌組成物
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
GB9015910D0 (en) * 1990-07-19 1990-09-05 Univ Bruxelles Novel use
US5389369A (en) * 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
US5336494A (en) * 1993-01-29 1994-08-09 Pellico Michael A Pet chewable products with enzymatic coating
US5453284A (en) * 1993-01-29 1995-09-26 Pellico; Michael A. Stabilized enzymatic dentifrice
WO1997042825A1 (en) * 1996-05-09 1997-11-20 Novo Nordisk A/S Antimicrobial peroxidase compositions
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
US6214339B1 (en) * 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats
GB0100643D0 (en) * 2001-01-10 2001-02-21 Basf Ag Liquid antimicrobial compositions
WO2003066001A2 (en) * 2002-02-07 2003-08-14 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
KR101108439B1 (ko) * 2002-10-25 2012-01-31 포믹스 리미티드 화장료 및 약제용 거품제
FR2860154B1 (fr) * 2003-09-29 2006-02-03 Chris Cardon Composition pour le traitement de la mauvaise haleine
JP4355592B2 (ja) * 2004-02-23 2009-11-04 森永乳業株式会社 抗ウイルス剤
WO2005085287A1 (en) * 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
DE602006003760D1 (de) * 2005-06-13 2009-01-22 Flen Pharma N V Zungen
CA2687128C (en) * 2006-05-10 2017-03-28 Laclede, Inc. Compositions and methods for enzymatic treatment of lung disorders
JP5337701B2 (ja) * 2006-10-10 2013-11-06 ラクリード、インコーポレイテッド ペルオキシド生成酵素及びペルオキシダーゼを使用した膣疾患の治療のための方法及び組成物
KR20150041172A (ko) * 2006-12-01 2015-04-15 래크리드 인코포레이티드 귀에서 균막을 용해시키기 위한 가수분해 및 산화 효소의 용도

Also Published As

Publication number Publication date
US20160279206A1 (en) 2016-09-29
JP5668200B2 (ja) 2015-02-12
WO2008045696A2 (en) 2008-04-17
CA2673497A1 (en) 2008-04-17
JP5337701B2 (ja) 2013-11-06
EP2073836A4 (en) 2010-04-07
KR20090094245A (ko) 2009-09-04
AU2007307921B2 (en) 2013-03-28
EP2073836A2 (en) 2009-07-01
AU2007307921A2 (en) 2009-05-21
JP2010505959A (ja) 2010-02-25
BRPI0719220A2 (pt) 2014-03-18
AU2007307921A1 (en) 2008-04-17
US20100111920A1 (en) 2010-05-06
WO2008045696A3 (en) 2009-04-16
JP2013107914A (ja) 2013-06-06

Similar Documents

Publication Publication Date Title
MX2009003925A (es) Metodos y composiciones para el tratamiento de enfermedades vaginales, empleando enzimas que producen peroxido y peroxidasas.
WO2007134180A3 (en) Compositions and methods for enzymatic treatment of lung disorders
GB0619786D0 (en) An antimicrobial and immunostimulatory system
WO2004061117A3 (en) Compositions and methods for enzymatic detachment of bacterial and fungal biofilms
WO2010080408A3 (en) Methods for increasing enzymatic hydrolysis of cellulosic material in the presence of a peroxidase
TW200609227A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MY153871A (en) Isoprene synthase variants for improved microbial production of isoprene
CA2747703C (en) Compositions and methods for the treatment or the prevention of infections by e. coli
MX2010007846A (es) Fabricación de enzimas sulfatasa lisosomal humana altamente fosforilada, activa y usos de las mismas.
MX2009004739A (es) Efectos biologicos mejorados de composiciones que comprenden acido rosmarinico.
EP1748767A4 (en) DIARYLALKANE AS A HIGHLY EFFICIENT HEMMER OF TWO-CORE ENZYMES
TW200801032A (en) Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
WO2006063055A3 (en) Enzyme conjugates for use as detoxifying agents
RU2008139609A (ru) Способ пивоварения
NZ706007A (en) Saccharide oxidase, and production method for same and use of same
MX2008005409A (es) Modulacion de la expresion de deshidrogenasa 1 de 11beta-hidroxiesteroide.
EA200970226A1 (ru) Термофильные микроорганизмы для производства этанола
WO2008019069A3 (en) Enzymatic aqueous acylation
WO2007130575A3 (en) Protection against oxidative damage in cells
SG136059A1 (en) 2-thioxothiazolidin-4-one compounds and compositions as antimicrobial and antimalarial agents targeting enoyl-acp reductase of type ii fatty acid synthesis pathway and other cell growth pathways
EP2583686A4 (en) AGENT FOR REDUCING ACETALDEHYDE IN THE ORAL CAVITY
WO2006047485A8 (en) Methods for lowering hif-1 mediated gene expression
WO2023178144A3 (en) Galnac compositions for improving sirna bioavailability
Shigetomi et al. MurA as a primary target of tulipalin B and 6-tuliposide B
TW200706653A (en) A process for improving the substrate specificity of the pyrroloquinoline quinone dependency glucose dehydrogenase

Legal Events

Date Code Title Description
FG Grant or registration